Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Thu, 13.03.2025
Mensch und Maschine Software SE
High future investments and record cashflow
- Dividend 185 Cents / +12% - 75 Cents payable pre-tax
- Mid-term target: doubling earnings in 4-5 years
Wessling, March 13, 2025 – Mensch und Maschine Software SE (MUM - ISIN DE0006580806), a CAD/CAM/BIM specialist company, today presents its Annual Report 2024, describing how M+M has laid a very good fo [ … ]
Thu, 13.03.2025
ecotel communication ag
Sales grow by 8% to 115.5 million EUR
Operating EBITDA grows by 5% to 9.5 million EUR,
consolidated profit of 2.0 million EUR, earnings per share of 0.57 EUR
Düsseldorf, 13.March 2025
In the 2024 financial year, ecotel has shown growth despite the challenging economic environment. Conditions have resulted in a solid outcome. Group sales in [ … ]
Thu, 13.03.2025
cyan AG
cyan AG achieves guidance for the 2024 financial year and plans further strong corporate growth
Consolidated operating sales of EUR 7.1 million achieved
Growth target of 50 % achieved compared to the previous year
Significant improvement in EBITDA to EUR -1.6 to -1.5 million
Investments in development and sales planned for further growth
Munic [ … ]
Thu, 13.03.2025
MLP SE
FY 2024: Earnings at upper end of forecast, revenue above one billion euros for the first time – significant growth planned up to 2028
FY 2024: Total revenue increased on a very broad basis and for the eleventh year in succession, new all-time high of EUR 1,067 million (plus 10 percent) achieved, compound annual growth rate (CAGR) of 9 percent sin [ … ]
Thu, 13.03.2025
Hannover Rück SE
Hannover Re significantly increases dividend after a highly successful 2024 financial year
Group net income rises by 28% to EUR 2.3 billion and reaches guidance, which had been revised higher in autumn 2024
Return on equity increases to 21.2% and clearly exceeds strategic target
Reinsurance revenue increases by 7.9% to EUR 26.4 billion
Opera [ … ]
Thu, 13.03.2025
Masterflex SE
Masterflex SE achieves record operating result in financial year 2024 according to preliminary figures
Consolidated sales revenue of EUR 98.1 million according to preliminary figures (previous year: EUR 101.1 million)
Record EBITDA of EUR 18.2 million (previous year: EUR 17.9 million) and operating EBIT of EUR 12.7 million (previous year: EUR 12. [ … ]
Thu, 13.03.2025
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
HealthCare Royalty and Heidelberg Pharma amend royalty financing agreement to provide for USD 20 million payment
Heidelberg Pharma extends cash runway into 2027
Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company [ … ]
Thu, 13.03.2025
grenke AG
grenke generates a EUR 70.2 million profit in 2024 and maintains growth trajectory
Group earnings 2024 reach EUR 70.2 million (2023: EUR 86.7 million)
Proposed dividend of EUR 0.40 per share (2023: EUR 0.47)
Guidance for 2025: Leasing new business between EUR 3.2 and EUR 3.4 billion and Group earnings in the range of EUR 71 to 81 million
Bade [ … ]
Thu, 13.03.2025
HELLA GmbH & Co. KGaA
LIPPSTADT (GERMANY)
13 March 2025
Fiscal Year 2024: FORVIA HELLA achieves solid financial results in a challenging industry environment
Currency-adjusted sales improve by 1.3 percent to €8.1 billion; reported sales of €8.0 billion remains at the previous year's level
Operating income falls to €446 million, among others due to underutiliza [ … ]
Thu, 13.03.2025
Nyxoah SA.
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
FDA PMA Application Review Nearing Conclusion
Positioned for U.S. Commercial Launch in the First Quarter 2025
Mont-Saint-Guibert, Belgium – March 13, 2025, 7:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that dev [ … ]